07 Sep 2023 by admin in UncategorizedComments NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen
05 Sep 2023 by admin in UncategorizedComments Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb
04 Sep 2023 by admin in UncategorizedComments Crescendo Biologics Wins Significant European Patent Office Ruling Related to the Engineering of Immunoglobulin Therapeutics
14 Aug 2023 by admin in UncategorizedComments Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia
24 Jul 2023 by admin in UncategorizedComments Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours
11 Jul 2023 by admin in UncategorizedComments Adicet Announces Appointment of Katie Peng to the Board of Directors
